These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33412935)

  • 1. CRISPR/Cas9 gene editing therapies for cystic fibrosis.
    Graham C; Hart S
    Expert Opin Biol Ther; 2021 Jun; 21(6):767-780. PubMed ID: 33412935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing.
    Guo T; Feng YL; Xiao JJ; Liu Q; Sun XN; Xiang JF; Kong N; Liu SC; Chen GQ; Wang Y; Dong MM; Cai Z; Lin H; Cai XJ; Xie AY
    Genome Biol; 2018 Oct; 19(1):170. PubMed ID: 30340517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells.
    Yan Z; Vorhies K; Feng Z; Park SY; Choi SH; Zhang Y; Winter M; Sun X; Engelhardt JF
    Hum Gene Ther; 2022 Oct; 33(19-20):1023-1036. PubMed ID: 35686451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
    Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
    J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways.
    Schimmel J; Muñoz-Subirana N; Kool H; van Schendel R; van der Vlies S; Kamp JA; de Vrij FMS; Kushner SA; Smith GCM; Boulton SJ; Tijsterman M
    Cell Rep; 2023 Feb; 42(2):112019. PubMed ID: 36701230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P.F508del editing in cells from cystic fibrosis patients.
    Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
    PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR-Cas9 technology in diabetes research.
    Lotfi M; Butler AE; Sukhorukov VN; Sahebkar A
    Diabet Med; 2024 Jan; 41(1):e15240. PubMed ID: 37833064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing.
    Denes CE; Cole AJ; Aksoy YA; Li G; Neely GG; Hesselson D
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases.
    Shaikh SB; Bhandary YP
    Curr Gene Ther; 2020; 20(5):333-346. PubMed ID: 33045965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
    Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
    Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for Enhancing the Homology-Directed Repair Efficiency of CRISPR-Cas Systems.
    Sun W; Liu H; Yin W; Qiao J; Zhao X; Liu Y
    CRISPR J; 2022 Feb; 5(1):7-18. PubMed ID: 35076280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Neurochem Int; 2018 Jan; 112():187-196. PubMed ID: 28732771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of CRISPR-Cas9 induced precise gene editing by targeting histone H2A-K15 ubiquitination.
    Bashir S; Dang T; Rossius J; Wolf J; Kühn R
    BMC Biotechnol; 2020 Oct; 20(1):57. PubMed ID: 33097066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.
    Miyaoka Y; Berman JR; Cooper SB; Mayerl SJ; Chan AH; Zhang B; Karlin-Neumann GA; Conklin BR
    Sci Rep; 2016 Mar; 6():23549. PubMed ID: 27030102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
    Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
    Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.